According to Cardinal Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 111.426. At the end of 2022 the company had a P/E ratio of -16.6.
Year | P/E ratio | Change |
---|---|---|
2022 | -16.6 | -161.91% |
2021 | 26.8 | 136.83% |
2020 | 11.3 | -419.24% |
2019 | -3.55 | -99.52% |
2018 | -743 | -7124.48% |
2017 | 10.6 | -38.25% |
2016 | 17.1 | -20.34% |
2015 | 21.5 | -12.87% |
2014 | 24.7 | -59.35% |
2013 | 60.7 | 391.14% |
2012 | 12.4 | -16.56% |
2011 | 14.8 | 4.46% |
2010 | 14.2 | -4.06% |
2009 | 14.8 | 49.31% |
2008 | 9.91 | -29.51% |
2007 | 14.1 | -20.62% |
2006 | 17.7 | -30.49% |
2005 | 25.5 | 26.11% |
2004 | 20.2 | 5.64% |
2003 | 19.1 | -8.62% |
2002 | 20.9 | -35.95% |
2001 | 32.7 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
CVS Health CVS | 11.9 | -89.30% | ๐บ๐ธ USA |
Henry Schein
HSIC | 21.8 | -80.45% | ๐บ๐ธ USA |
Teleflex TFX | 26.0 | -76.64% | ๐บ๐ธ USA |
AmerisourceBergen
ABC | 21.7 | -80.52% | ๐บ๐ธ USA |
McKesson MCK | 21.2 | -81.01% | ๐บ๐ธ USA |
Premier PINC | 14.2 | -87.30% | ๐บ๐ธ USA |
Patterson Companies
PDCO | 12.6 | -88.71% | ๐บ๐ธ USA |
Allscripts MDRX | 15.6 | -86.00% | ๐บ๐ธ USA |
Owens & Minor
OMI | -21.7 | -119.44% | ๐บ๐ธ USA |
Herbalife HLF | 5.04 | -95.48% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.